Overview
United Theranostics is a leader in precision cancer care, specializing in advanced, individualized treatment for metastatic prostate cancer, metastatic neuroendocrine cancer, and thyroid cancer. Our mission is to deliver the most effective, patient-centered therapies by combining state-of-the-art molecular imaging with tailored treatment plans, ensuring every patient receives care designed for their unique needs.
Founded by experts in oncology, nuclear medicine, and radiology, United Theranostics was established to bring the promise of theranostics, a field that unites diagnostic imaging and targeted therapy directly to patients. Since our inception, we have grown to operate clinics in Bethesda, MD; Glen Burnie, MD; Princeton, NJ; and Las Cruces, NM, making advanced cancer care accessible across multiple states.
Our Vision
To transform cancer treatment by making precision, molecular-level care the standard for all patients, regardless of location.
Our Values
Patient-Centered Care: Every decision and treatment plan is guided by what’s best for the individual patient.
Innovation: We embrace the latest advances in molecular imaging and targeted therapies to improve outcomes.
Collaboration: Our multidisciplinary team works closely with referring oncologists, urologists, endocrinologists, and other healthcare providers to ensure seamless, coordinated care.
Compassion: We support patients and their families at every step, from diagnosis to survivorship.
Executive Team
Robert Cherney
Chief Executive Officer
Seth Van Vorhees
Chief Financial Officer
Munir Ghesani, MD
Chief Medical Officer
Physician Founders
Eliot Siegel, MD
Nuclear Medicine
Sub-specialization
Fellow American College of Radiology
Fellow Society of Imaging Informatics in Medicine
Babak Saboury, MD
Diplomate American Board of Radiology
Diplomate Clinical Informatics
Michael Morris, MD
Diplomate American Board of Radiology
Diplomate Clinical Informatics